![Ingrid Müller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ingrid Müller
Chief Operating Officer at
EVOTEC SE
Profile
Ingrid Müller is Chief Operating Officer at Evotec SE since 2026.
Dr. Müller was Vice President-Portfolio Strategy & Execution at CureVac NV from 2024 to 2026.
Ingrid Müller active positions
| Companies | Position | Start |
|---|---|---|
| EVOTEC SE | Chief Operating Officer | 01/05/2026 |
Former positions of Ingrid Müller
| Companies | Position | End |
|---|---|---|
| CUREVAC | Corporate Officer/Principal | 01/01/2026 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
- Stock Market
- Insiders
- Ingrid Müller
